0001181431-13-016080.txt : 20130311
0001181431-13-016080.hdr.sgml : 20130311
20130311175950
ACCESSION NUMBER: 0001181431-13-016080
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130307
FILED AS OF DATE: 20130311
DATE AS OF CHANGE: 20130311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Thorndike William N Jr
CENTRAL INDEX KEY: 0001437827
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33092
FILM NUMBER: 13682031
MAIL ADDRESS:
STREET 1: HOUSATONIC PARTNERS
STREET 2: 800 BOYLSTON STREET, SUITE 2220
CITY: BOSTON
STATE: MA
ZIP: 02199
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LEMAITRE VASCULAR INC
CENTRAL INDEX KEY: 0001158895
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 63 2ND AVE
CITY: BURLINGTON
STATE: MA
ZIP: 01803
BUSINESS PHONE: 781-221-2266
MAIL ADDRESS:
STREET 1: 63 2ND AVE
CITY: BURLINGTON
STATE: MA
ZIP: 01803
4
1
rrd373733.xml
THORNDIKE FORM 4 2013-3-7
X0306
4
2013-03-07
0
0001158895
LEMAITRE VASCULAR INC
LMAT
0001437827
Thorndike William N Jr
C/O LEMAITRE VASCULAR, INC.
63 SECOND AVENUE
BURLINGTON
MA
01803
1
0
0
0
Common Stock
2013-03-07
4
S
0
10000
6.00
D
11529
I
See footnote
Common Stock
2013-03-08
4
S
0
600
6.0183
D
10929
I
See footnote
Common Stock
87202
D
These shares are held by Housatonic Equity Investors L.P. Housatonic Equity Partners I, LLC is the general partner of Housatonic Equity Investors L.P., and William N. Thorndike, Jr. is a managing director of Housatonic Equity Partners I, LLC and a limited partner of Housatonic Equity Investors L.P. In such capacities the reporting person may be deemed to share voting and investment power with respect to the securities held of record by Housatonic Equity Investors L.P. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for purposes of Section 16 or for any other purpose.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $6.00 to $6.03. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
/s/ Laurie Churchill, Attorney-in-Fact
2013-03-11